Ra Capital Management, L.P. Axsome Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 1,000,000 shares of AXSM stock, worth $97.8 Million. This represents 1.25% of its overall portfolio holdings.
Number of Shares
1,000,000
Previous 1,000,000
-0.0%
Holding current value
$97.8 Million
Previous $80.5 Million
11.61%
% of portfolio
1.25%
Previous 1.21%
Shares
11 transactions
Others Institutions Holding AXSM
# of Institutions
308Shares Held
40.3MCall Options Held
429KPut Options Held
615K-
Rtw Investments, LP New York, NY4.19MShares$410 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$391 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$323 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$231 Million34.46% of portfolio
-
Macquarie Group LTD Australia, C3995KShares$97.4 Million0.1% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.19B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...